From May 1, 2023 to July 31, 2023, the company has repurchased 101,000 shares, representing 0.75% for $0.6 million. With this, the company has completed the repurchase of 115,000 shares, representing 0.85% for $0.68 million under the buyback announced on April 5, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.869 USD | +0.19% | -3.77% | -13.36% |
Mar. 15 | Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023. | CI |
Mar. 13 | Craig-Hallum Downgrades Champions Oncology to Hold From Buy | MT |
1st Jan change | Capi. | |
---|---|---|
-13.36% | 66.07M | |
+26.28% | 42.68B | |
-3.99% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+6.36% | 24.94B | |
-21.47% | 18.96B | |
+27.58% | 12.3B | |
-2.75% | 11.95B | |
-2.02% | 11.55B |
- Stock Market
- Equities
- CSBR Stock
- News Champions Oncology, Inc.
- Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023.